Silicon Laboratories Inc. (NASDAQ:SLAB) Director Jack R. Lazar sold 4,000 shares of the business’s stock in a transaction on Wednesday, October 5th. The shares were sold at an average price of $60.00, for a total value of $240,000.00. Following the completion of the sale, the director now directly owns 13,324 shares in the company, valued at approximately $799,440. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Silicon Laboratories Inc. (NASDAQ:SLAB) opened at 59.46 on Friday. The stock’s 50 day moving average price is $56.85 and its 200 day moving average price is $50.60. The firm has a market cap of $2.47 billion, a price-to-earnings ratio of 67.57 and a beta of 1.42. Silicon Laboratories Inc. has a 52 week low of $36.56 and a 52 week high of $60.00.
Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Wednesday, July 27th. The company reported $0.75 EPS for the quarter, topping the Zacks’ consensus estimate of $0.64 by $0.11. Silicon Laboratories had a return on equity of 8.71% and a net margin of 5.66%. The firm had revenue of $174.90 million for the quarter, compared to analyst estimates of $170.52 million. During the same quarter last year, the company earned $0.56 EPS. The company’s revenue was up 6.1% on a year-over-year basis. On average, equities research analysts predict that Silicon Laboratories Inc. will post $2.54 EPS for the current year.
Institutional investors have recently bought and sold shares of the company. Bank of Montreal Can bought a new position in Silicon Laboratories during the second quarter worth approximately $132,000. Hermes Investment Management Ltd. raised its position in Silicon Laboratories by 18.2% in the second quarter. Hermes Investment Management Ltd. now owns 909,087 shares of the company’s stock worth $44,309,000 after buying an additional 140,260 shares during the period. LS Investment Advisors LLC raised its position in Silicon Laboratories by 74.3% in the second quarter. LS Investment Advisors LLC now owns 2,336 shares of the company’s stock worth $114,000 after buying an additional 996 shares during the period. BNP Paribas Arbitrage SA raised its position in Silicon Laboratories by 2,034.3% in the second quarter. BNP Paribas Arbitrage SA now owns 18,291 shares of the company’s stock worth $892,000 after buying an additional 17,434 shares during the period. Finally, Boothbay Fund Management LLC bought a new position in Silicon Laboratories during the first quarter worth approximately $298,000. Hedge funds and other institutional investors own 87.46% of the company’s stock.
Several analysts recently commented on the company. Needham & Company LLC reaffirmed a “hold” rating on shares of Silicon Laboratories in a research note on Wednesday. Stifel Nicolaus reaffirmed a “buy” rating and issued a $67.00 price target (up previously from $65.00) on shares of Silicon Laboratories in a research note on Friday, August 26th. Roth Capital initiated coverage on Silicon Laboratories in a research note on Wednesday, September 28th. They issued a “buy” rating and a $65.00 price objective on the stock. Zacks Investment Research lowered Silicon Laboratories from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 28th. Finally, Drexel Hamilton reissued a “buy” rating and issued a $52.00 price objective on shares of Silicon Laboratories in a research note on Thursday, July 28th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Silicon Laboratories has an average rating of “Buy” and a consensus price target of $57.91.
Silicon Laboratories Company Profile